Cargando…
PM423. Blonanserin augmentation in patients with schizophrenia – who is benefited from blonanserin augmentation?: An open-label, prospective, multicenter study
| Autores principales: | , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616358/ http://dx.doi.org/10.1093/ijnp/pyw041.423 |
| _version_ | 1783266763283103744 |
|---|---|
| author | Woo, Young Sup Park, Joo Eon Kim, Do-Hoon Sohn, Inki Hwang, Tae-Yeon Park, Young-Min Jon, Duk-In Jeong, Jong-Hyun Bahk, Won-Myong Woo, Y. S. Jeong, J. H. Bahk, W. M. Sohn, I. K. Park, J. E. Kim, D. H. Hwang, T. Y. Park, Y. M. Jon, D. I. |
| author_facet | Woo, Young Sup Park, Joo Eon Kim, Do-Hoon Sohn, Inki Hwang, Tae-Yeon Park, Young-Min Jon, Duk-In Jeong, Jong-Hyun Bahk, Won-Myong Woo, Y. S. Jeong, J. H. Bahk, W. M. Sohn, I. K. Park, J. E. Kim, D. H. Hwang, T. Y. Park, Y. M. Jon, D. I. |
| author_sort | Woo, Young Sup |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5616358 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2016 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-56163582017-11-27 PM423. Blonanserin augmentation in patients with schizophrenia – who is benefited from blonanserin augmentation?: An open-label, prospective, multicenter study Woo, Young Sup Park, Joo Eon Kim, Do-Hoon Sohn, Inki Hwang, Tae-Yeon Park, Young-Min Jon, Duk-In Jeong, Jong-Hyun Bahk, Won-Myong Woo, Y. S. Jeong, J. H. Bahk, W. M. Sohn, I. K. Park, J. E. Kim, D. H. Hwang, T. Y. Park, Y. M. Jon, D. I. Int J Neuropsychopharmacol Abstracts Oxford University Press 2016-05-27 /pmc/articles/PMC5616358/ http://dx.doi.org/10.1093/ijnp/pyw041.423 Text en © The Author 2016. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com. |
| spellingShingle | Abstracts Woo, Young Sup Park, Joo Eon Kim, Do-Hoon Sohn, Inki Hwang, Tae-Yeon Park, Young-Min Jon, Duk-In Jeong, Jong-Hyun Bahk, Won-Myong Woo, Y. S. Jeong, J. H. Bahk, W. M. Sohn, I. K. Park, J. E. Kim, D. H. Hwang, T. Y. Park, Y. M. Jon, D. I. PM423. Blonanserin augmentation in patients with schizophrenia – who is benefited from blonanserin augmentation?: An open-label, prospective, multicenter study |
| title | PM423. Blonanserin augmentation in patients with schizophrenia – who is benefited from blonanserin augmentation?: An open-label, prospective, multicenter study |
| title_full | PM423. Blonanserin augmentation in patients with schizophrenia – who is benefited from blonanserin augmentation?: An open-label, prospective, multicenter study |
| title_fullStr | PM423. Blonanserin augmentation in patients with schizophrenia – who is benefited from blonanserin augmentation?: An open-label, prospective, multicenter study |
| title_full_unstemmed | PM423. Blonanserin augmentation in patients with schizophrenia – who is benefited from blonanserin augmentation?: An open-label, prospective, multicenter study |
| title_short | PM423. Blonanserin augmentation in patients with schizophrenia – who is benefited from blonanserin augmentation?: An open-label, prospective, multicenter study |
| title_sort | pm423. blonanserin augmentation in patients with schizophrenia – who is benefited from blonanserin augmentation?: an open-label, prospective, multicenter study |
| topic | Abstracts |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616358/ http://dx.doi.org/10.1093/ijnp/pyw041.423 |
| work_keys_str_mv | AT wooyoungsup pm423blonanserinaugmentationinpatientswithschizophreniawhoisbenefitedfromblonanserinaugmentationanopenlabelprospectivemulticenterstudy AT parkjooeon pm423blonanserinaugmentationinpatientswithschizophreniawhoisbenefitedfromblonanserinaugmentationanopenlabelprospectivemulticenterstudy AT kimdohoon pm423blonanserinaugmentationinpatientswithschizophreniawhoisbenefitedfromblonanserinaugmentationanopenlabelprospectivemulticenterstudy AT sohninki pm423blonanserinaugmentationinpatientswithschizophreniawhoisbenefitedfromblonanserinaugmentationanopenlabelprospectivemulticenterstudy AT hwangtaeyeon pm423blonanserinaugmentationinpatientswithschizophreniawhoisbenefitedfromblonanserinaugmentationanopenlabelprospectivemulticenterstudy AT parkyoungmin pm423blonanserinaugmentationinpatientswithschizophreniawhoisbenefitedfromblonanserinaugmentationanopenlabelprospectivemulticenterstudy AT jondukin pm423blonanserinaugmentationinpatientswithschizophreniawhoisbenefitedfromblonanserinaugmentationanopenlabelprospectivemulticenterstudy AT jeongjonghyun pm423blonanserinaugmentationinpatientswithschizophreniawhoisbenefitedfromblonanserinaugmentationanopenlabelprospectivemulticenterstudy AT bahkwonmyong pm423blonanserinaugmentationinpatientswithschizophreniawhoisbenefitedfromblonanserinaugmentationanopenlabelprospectivemulticenterstudy AT wooys pm423blonanserinaugmentationinpatientswithschizophreniawhoisbenefitedfromblonanserinaugmentationanopenlabelprospectivemulticenterstudy AT jeongjh pm423blonanserinaugmentationinpatientswithschizophreniawhoisbenefitedfromblonanserinaugmentationanopenlabelprospectivemulticenterstudy AT bahkwm pm423blonanserinaugmentationinpatientswithschizophreniawhoisbenefitedfromblonanserinaugmentationanopenlabelprospectivemulticenterstudy AT sohnik pm423blonanserinaugmentationinpatientswithschizophreniawhoisbenefitedfromblonanserinaugmentationanopenlabelprospectivemulticenterstudy AT parkje pm423blonanserinaugmentationinpatientswithschizophreniawhoisbenefitedfromblonanserinaugmentationanopenlabelprospectivemulticenterstudy AT kimdh pm423blonanserinaugmentationinpatientswithschizophreniawhoisbenefitedfromblonanserinaugmentationanopenlabelprospectivemulticenterstudy AT hwangty pm423blonanserinaugmentationinpatientswithschizophreniawhoisbenefitedfromblonanserinaugmentationanopenlabelprospectivemulticenterstudy AT parkym pm423blonanserinaugmentationinpatientswithschizophreniawhoisbenefitedfromblonanserinaugmentationanopenlabelprospectivemulticenterstudy AT jondi pm423blonanserinaugmentationinpatientswithschizophreniawhoisbenefitedfromblonanserinaugmentationanopenlabelprospectivemulticenterstudy |